No Data
No Data
HK Stock market anomaly | QUANTUMPH-P (02228) down more than 6% in intraday trading. The company is an AI pharmaceutical enterprise, and CICC claims that it is expected to enter the Hong Kong stock exchange through the Stock Connect program in the near fu
QUANTUMPH-P (02228) fell more than 6% during trading, and as of press time, it has fallen 1.64% to HKD 5.4, with a turnover of HKD 2.4016 million.
CMB International Starts QuantumPharm at Buy With HK$7.25 Price Target
QuantumPharm Could Be a Potential M&A Target -- Market Talk
QuantumPharm Started at Buy by Jefferies >2228.HK
QUANTUMPH-P (02228) issued 8.796 million shares based on partial exercise of the excess rights issue.
ZHITONGCAIJING APP news, QUANTUMPH-P (02228) announced that on July 10, 2024, 8.796 million ordinary shares were issued and distributed based on the partial exercise of the over-allotment option.
QUANTUM PH-P (02228.HK): Partial exercise of the over-allotment option, involving a total of 8.796 million shares.
On July 7th, Guolong reported that QUANTUM PH-P (02228.HK) announced that the oversubscription rights described in the prospectus have been partially exercised by the joint coordinators (on behalf of the company and the international underwriters) and involve a total of 8.796 million shares, equivalent to approximately 4.69% of the total number of sale shares preliminarily available for subscription under the global offering before any oversubscription rights were exercised. The excess shares will be issued by the company at a price of HKD 5.28 per share. The excess shares will be used to encourage Citic Lyon Securities (Stabilization Merchant) to subscribe to QuantumPharm.
No Data